Literature DB >> 26670578

Skene's gland cyst excision.

Jeannine Foster1, Gary Lemack1, Philippe Zimmern2.   

Abstract

INTRODUCTION AND HYPOTHESIS: We review our experience with long-term outcome after Skene's gland cyst excision.
MATERIALS AND METHODS: After receiving institutional review board approval, we reviewed a surgical database of all procedures performed by two surgeons at one institution for Skene's gland cyst excision. Parameters evaluated include presenting symptoms, preoperative evaluation, excision site, perioperative complications, and clinical outcomes. The technique of surgical excision is presented in the accompanying video, and includes cystoscopy, dissection of cyst wall from the floor of the urethra, complete removal of the cyst wall, and primary vaginal-wall closure.
RESULTS: From 2001 to 2013, ten women underwent Skene's gland cyst excision. Mean follow-up was 3.5 years (range 3-96 months). Presenting symptoms were dyspareunia (4), urinary tract infections (4), vaginal mass (1), and voiding dysfunction (1). Five patients had more than one presenting symptom. To exclude urethral diverticulum, magnetic resonance imaging (MRI) was done in all patients and a voiding cystourethrogram in five. No perioperative complications were reported. A distal meatoplasty was done in two women. No recurrence occurred. Eight of ten women who were sexually active remained sexually active postoperatively.
CONCLUSIONS: Excision of Skene's gland cyst is a safe procedure with acceptable long-term functional outcomes.

Entities:  

Keywords:  Excision; Outcome; Skene’s gland cyst

Mesh:

Year:  2015        PMID: 26670578     DOI: 10.1007/s00192-015-2872-9

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  9 in total

1.  Paraurethral cyst in adult women: experience with 85 cases.

Authors:  Farzaneh Sharifiaghdas; Farzaneh Shaririaghdas; Azar Daneshpajooh; Mahboubeh Mirzaei
Journal:  Urol J       Date:  2014-11-01       Impact factor: 1.510

2.  Surgical management of Skene's gland abscess/infection: a contemporary series.

Authors:  Sagar R Shah; Grace Y Biggs; Nirit Rosenblum; Victor W Nitti
Journal:  Int Urogynecol J       Date:  2011-07-06       Impact factor: 2.894

3.  Skene's duct cyst in a newborn: case report and review of the literature.

Authors:  H M Kimbrough; E D Vaughan
Journal:  J Urol       Date:  1977-03       Impact factor: 7.450

4.  Paraurethral cysts in women.

Authors:  S P Das
Journal:  J Urol       Date:  1981-07       Impact factor: 7.450

5.  Skene's duct cyst.

Authors:  E V Miller
Journal:  J Urol       Date:  1984-05       Impact factor: 7.450

Review 6.  Benign female periurethral masses.

Authors:  R R Dmochowski; K Ganabathi; P E Zimmern; G E Leach
Journal:  J Urol       Date:  1994-12       Impact factor: 7.450

7.  Prepubertal Skene's abscess.

Authors:  S Walker Nickles; Judith T Burgis; Seema Menon; Janice L Bacon
Journal:  J Pediatr Adolesc Gynecol       Date:  2009-02       Impact factor: 1.814

Review 8.  Benign cystic lesions of the vagina: a literature review.

Authors:  Karyn Schlunt Eilber; Shlomo Raz
Journal:  J Urol       Date:  2003-09       Impact factor: 7.450

9.  Experiences with the management of paraurethral cysts in adult women.

Authors:  Osman Köse; Hüseyin Aydemir; Osman Metin; Salih Budak; Adil Sonbahar; Oztuğ Adsan
Journal:  Cent European J Urol       Date:  2014-01-27
  9 in total
  3 in total

1.  Skene's gland cyst: a simple marsupialization technique.

Authors:  Martin Laura; Chandrasekaran Neeraja; Benardete Denise; Cariello Lisa; Davila Guillermo Willy
Journal:  Int Urogynecol J       Date:  2016-12-28       Impact factor: 2.894

Review 2.  Urethral Pathology in Women.

Authors:  Erin Maetzold; Elizabeth B Takacs
Journal:  Curr Urol Rep       Date:  2022-09-17       Impact factor: 2.862

3.  Adult-onset Skene's gland cyst following a history of multiple gynecological treatment interventions.

Authors:  Toshitaka Shin; Ryuta Sato; Tadamasa Shibuya; Tadasuke Ando; Hiromitsu Mimata
Journal:  Urol Case Rep       Date:  2021-01-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.